Recalls / Active ingredient / Soybean Oil
Soybean Oil
4 FDA drug recalls involving the active ingredient “Soybean Oil” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-04-13 | Class II | Intralipid (I.V. Fat emulsion), 20%, 250 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-09 | Mckesson Medical-Surgical Inc. Corporate Office |
| 2022-04-13 | Class II | Intralipid (I.V. Fat emulsion), 20%, 100 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-58 | Mckesson Medical-Surgical Inc. Corporate Office |
| 2017-09-15 | Class I | Intralipid 20%, A 20% I.V. Fat Emulsion, 100 ml bag, Rx only, Manufactured by Fresenius Kabi, Uppsala, Sweden | Baxter Healthcare Corporation |
| 2015-04-28 | Class II | KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfit | Fresenius Kabi USA, LLC |